My Watchlist

Top Indices

SPX

My Portfolio

Bausch Health Companies Inc. Common Stock (NY:BHC)

6.280 -0.340 (-5.14%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗

August 31, 2022

Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in...

Via Benzinga

Snap, Meta Platforms, Pinterest And Some Other Big Stocks Moving Higher On Wednesday ↗

August 31, 2022

Barnes & Noble Education, Inc. (NYSE: BNED) gained 16.8% to $2.64 after reporting upbeat quarterly sales. Bausch Health Companies Inc. (NYSE: BHC) gained 15.5% to $5.91.

Via Benzinga

'Well-Established' Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst ↗

July 26, 2022

Via Benzinga

Expert Ratings for Bausch Health Companies ↗

July 26, 2022

Bausch Health Companies (NYSE:BHC) has observed the following analyst ratings within the last quarter:

Via Benzinga

Could This Company's HyBryte™ Provide A Safer, More Convenient Alternative To Cutaneous T-Cell Lymphoma Treatment? ↗

August 17, 2022

Patients always have hope if their cancers are detected early. Thanks to advanced research and therapies, the earlier the cancer is diagnosed and treated, the better the chance of it being cured.

Via Benzinga

Bausch Health Companies Inc. (NYSE:BHC) Shareholder Notice: Investigation over Potential Wrongdoing ↗

August 12, 2022

San Diego, CA -- (SBWIRE) -- 08/12/2022 -- An investigation as announced over potential breaches of fiduciary duties by certain directors at Bausch Health Companies Inc.

Via SBWire

7 Stock Price Predictions That Are Actually Worth Listening To ↗

August 12, 2022

Investors may take advantage of analyst stock price predictions beyond the recent share price to discover promising investments.

Via InvestorPlace

Recap: Bausch Health Companies Q2 Earnings ↗

August 09, 2022

Bausch Health Companies (NYSE:BHC) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Bausch Health Companies...

Via Benzinga

BHC Stock Continues to Fall as Bausch Health Responds to Court Decision ↗

July 29, 2022

Although Bausch Health promises to fight back against an unfavorable patent protection ruling, BHC stock is still hurting.

Via InvestorPlace

This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday ↗

August 01, 2022

Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings...

Via Benzinga

Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session ↗

July 29, 2022

Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022 ↗

July 29, 2022

Via Benzinga

Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update ↗

July 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga Before The Bell: Apple's Strong China Revenue, Amazon's EV Partnership, Jack Ma To Cede Control Of Ant Financial And Other Top Financial Stories Friday, July 29 ↗

July 29, 2022

Reuters Tencent’s Overseas Ambitions Face Resistance From India

Via Benzinga

Bausch Health To Appeal Expected Court Decision On Xifaxan Patents ↗

July 29, 2022

Yesterday, Bausch Health Companies Inc (NYSE: BHC) stock closed 50% lower after the reports on the order on patent litigation over Xifaxan (rifaximin).

Via Benzinga

Nasdaq Rises 100 Points; US Economy Shrinks Again In Q2 ↗

July 28, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday.

Via Benzinga

This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday ↗

July 29, 2022

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...

Via Benzinga

Why Bausch Health's Market Cap Is Being Cut In Half Thursday: 'A Near Worst-Case Scenario' ↗

July 28, 2022

Shares of global health company Bausch Health Companies Inc (NYSE: BHC) are plunging Thursday after a Delaware federal judge issued an oral order on patents related to the company's Xifaxan drug.

Via Benzinga

Bausch Health (BHC) Stock Plunges 50% on Patent News ↗

July 28, 2022

With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Thursday ↗

July 28, 2022

On Thursday, 108 companies set new 52-week lows.

Via Benzinga

Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session ↗

July 28, 2022

Gainers

Via Benzinga

Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday ↗

July 28, 2022

Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan.

Via Benzinga

Nasdaq Dips Over 100 Points; Meta Earnings Miss Estimates ↗

July 28, 2022

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Thursday.

Via Benzinga

NIO Stock Falls as Grizzly Research Targets the EV Maker in New Short Report ↗

June 28, 2022

Shares of NIO stock are sinking lower today following the release of a Grizzly Research short report. Here's what you should know.

Via InvestorPlace

Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday ↗

June 27, 2022

Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...

Via Benzinga

Opening Day: Golden Sun Rises In Debut As Ivanhoe Electric Delays IPO ↗

June 26, 2022

Chinese tutorial services provider Golden Sun Education opened for trading this week, with its shares surging almost 300% following a $17.6 million initial public offering. Meanwhile, Ivanhoe Electric...

Via Talk Markets

Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session ↗

June 24, 2022

Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.

Via Benzinga

Bausch Health to Postpone Its Planned Initial Public Offering (Ipo) of Its Solta Medical Skin-care Division Due to Market Instability.

June 17, 2022

The IPO process for Solta drew "substantial investor interest," according to a statement released by Bausch Health. "However, the business

Via Best Stocks

Topics Initial Public Offering

Cramer Gives His Opinion On Equinix, Bausch Health And More ↗

June 15, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Bausch Health Companies Inc.

Via Benzinga

Bausch Health Companies Earnings Perspective: Return On Capital Employed ↗

June 09, 2022

Benzinga Pro data, Bausch Health Companies (NYSE:BHC) reported Q1 sales of $1.92 billion. Earnings fell to a loss of $66.00 million, resulting in a 191.67% decrease from last quarter.

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.